Articles

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Record identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Full title

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Publisher

England: Nature Publishing Group

Journal title

Nature reviews. Clinical oncology, 2018, Vol.15 (1), p.47-62

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403

Language

English

Formats

Publication information

Publisher

England: Nature Publishing Group

More information

SCOPE AND CONTENTS

Contents

Immunotherapy using T cells genetically engineered to express a chimeric antigen receptor (CAR) is rapidly emerging as a promising new treatment for haematological and non-haematological malignancies. CAR-T-cell therapy can induce rapid and durable clinical responses, but is associated with unique acute toxicities, which can be severe or even fatal...

ALTERNATIVE TITLES

Full title

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403

OTHER IDENTIFIERS

ISSN

1759-4774

E-ISSN

1759-4782

DOI

10.1038/nrclinonc.2017.148

How to access this item

Online

1 item

How to access?

Login with a Library card